financetom
Business
financetom
/
Business
/
Looking At MicroStrategy's Recent Unusual Options Activity
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Looking At MicroStrategy's Recent Unusual Options Activity
Jul 16, 2024 8:36 AM

Deep-pocketed investors have adopted a bullish approach towards MicroStrategy ( MSTR ) , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in MSTR usually suggests something big is about to happen.

We gleaned this information from our observations today when Benzinga's options scanner highlighted 110 extraordinary options activities for MicroStrategy ( MSTR ). This level of activity is out of the ordinary.

The general mood among these heavyweight investors is divided, with 40% leaning bullish and 38% bearish. Among these notable options, 20 are puts, totaling $2,155,752, and 90 are calls, amounting to $5,551,237.

Projected Price Targets

Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $560.0 to $3800.0 for MicroStrategy ( MSTR ) during the past quarter.

Analyzing Volume & Open Interest

In today's trading context, the average open interest for options of MicroStrategy ( MSTR ) stands at 228.31, with a total volume reaching 7,257.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in MicroStrategy ( MSTR ), situated within the strike price corridor from $560.0 to $3800.0, throughout the last 30 days.

MicroStrategy Call and Put Volume: 30-Day Overview

Noteworthy Options Activity:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Price Open Interest Volume
MSTR PUT TRADE NEUTRAL 11/15/24 $83.7 $77.2 $80.1 $1020.00 $760.9K 2 0
MSTR CALL TRADE NEUTRAL 02/21/25 $537.7 $522.0 $531.3 $1460.00 $265.6K 2 0
MSTR CALL TRADE BEARISH 02/21/25 $536.0 $526.75 $526.75 $1450.00 $263.3K 92 0
MSTR CALL TRADE BEARISH 07/19/24 $608.0 $594.1 $599.42 $1000.00 $179.8K 384 0
MSTR CALL TRADE BEARISH 08/30/24 $91.0 $87.0 $87.0 $2000.00 $174.0K 8 0

About MicroStrategy

MicroStrategy Inc ( MSTR ) is a provider of enterprise analytics and mobility software. It offers MicroStrategy Analytics platform that delivers reports and dashboards and enables users to conduct ad hoc analysis and share insights through mobile devices or the Web; MicroStrategy Server, which provides analytical processing and job management. The company's reportable operating segment is engaged in the design, development, marketing, and sales of its software platform through licensing arrangements and cloud-based subscriptions and related services.

MicroStrategy's Current Market Status

Trading volume stands at 516,772, with MSTR's price down by -0.61%, positioned at $1601.39.

RSI indicators show the stock to be may be approaching overbought.

Earnings announcement expected in 16 days.

Expert Opinions on MicroStrategy

A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $1847.0.

Maintaining their stance, an analyst from Canaccord Genuity continues to hold a Buy rating for MicroStrategy ( MSTR ), targeting a price of $1826.

In a cautious move, an analyst from Maxim Group downgraded its rating to Buy, setting a price target of $1835.

An analyst from TD Cowen persists with their Buy rating on MicroStrategy ( MSTR ), maintaining a target price of $1880.

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for MicroStrategy ( MSTR ) with Benzinga Pro for real-time alerts.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Durect Gets FDA Breakthrough Therapy Designation for Alcohol-Related Hepatitis Treatment
Durect Gets FDA Breakthrough Therapy Designation for Alcohol-Related Hepatitis Treatment
May 21, 2024
11:17 AM EDT, 05/21/2024 (MT Newswires) -- Durect ( DRRX ) said Tuesday it obtained the breakthrough therapy designation from the US Food and Drug Administration for larsucosterol to treat people with severe alcohol-associated hepatitis. The designation is backed by results from a phase 2b trial that assessed the safety and efficacy of larsucosterol, the company said. Durect ( DRRX...
Market Chatter: SEC Asks Nasdaq, CBOE, NYSE to Adjust Filings for Ether ETF Listing
Market Chatter: SEC Asks Nasdaq, CBOE, NYSE to Adjust Filings for Ether ETF Listing
May 21, 2024
11:17 AM EDT, 05/21/2024 (MT Newswires) -- Nasdaq (NDAQ), Cboe Global Markets ( CBOE ) and the New York Stock Exchange were asked by the US Securities and Exchange Commission to fine-tune listing applications for ether exchange-traded-funds, Reuters reported Tuesday, citing four people familiar with the process. Such requests from the SEC usually signal that the agency may be poised...
--Street Color: Walt Disney's Pixar Unit Reportedly Cutting 14% of Workforce
--Street Color: Walt Disney's Pixar Unit Reportedly Cutting 14% of Workforce
May 21, 2024
11:17 AM EDT, 05/21/2024 (MT Newswires) -- (Street Color news is derived from real time discussions with market professionals globally subscribed to the Street Color Premium Chat service on Bloomberg IB Chat and the ICE IM. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.) Price: 103.34, Change: +0.44, Percent...
GT Biopharma Prices $3.2 Million Registered Direct Offering of Shares, Concurrent Private Placement of Warrants
GT Biopharma Prices $3.2 Million Registered Direct Offering of Shares, Concurrent Private Placement of Warrants
May 21, 2024
11:19 AM EDT, 05/21/2024 (MT Newswires) -- GT Biopharma ( GTBP ) said Tuesday it priced a registered direct offering of 740,000 common shares at $4.35 per share for expected gross proceeds of about $3.2 million. The company is also issuing warrants to purchase 740,000 shares with an exercise price of $4.35 per share in a concurrent private placement. The...
Copyright 2023-2026 - www.financetom.com All Rights Reserved